Augmentation of Streptokinase-Induced Thrombolysis by Heparin and Prostacyclin
- 30 June 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 7 (4), 739-746
- https://doi.org/10.1097/00005344-198507000-00019
Abstract
The ability of heparin and prostacyclin to improve streptokinase-induced recanalization was examined in open-chest dogs subjected to thrombotic occluson of the left circumflex coronary artery. Vessel injury was produced by electrical stimulation of the intimal surface at the site of a noncircumferential fixed stenosis. Animals were divided into 3 treatment groups as follows: group 1 received intracoronary streptokinase alone (75,000 U/80 min starting 30 min postocclusion; n = 8); group 2 received streptokinase plus heparin (300 U/kg i.v. at 20 min postocclusion; n = 7); group 3 received streptokinase plus heparin prostacyclin (500 ng/kg per min, intracoronary, given intermittently during reperfusion; n = 7). The groups did not differ with respect to preocclusion coronary blood flow (27 .+-. 1 ml/min; .+-. SEM [standard error of the mean]), the duration of streptokinase infusion required to achieve reflow (15 .+-. 2 min), and the percentage of animals recanalized (85%). They did differ in the average rate of reflow, which was greater in group 2 (16 .+-. 2 ml/min) and group 3 (20 .+-. 4 ml/min) as compared with group 1 (6 .+-. 1 ml/min P < 0.05). The intermittent reocclusions which persisted during reperfusion in group 1 and 2 dogs were diminished during the periodic infusions of prostacyclin. Thrombus mass at the site of injury was comparable among groups. In contrast, distal circumflex thrombi, about twice the weight of the proximal mass, were observed in all groups 1 dogs and were undetectable in group 2 and 3 animals. Transient improvements in contractile force during reperfusion were observed only with groups 2 and 3. Heparin and prostacyclin are effective in increasing antegrade flow during recanalization achieved with thrombolytic therapy.This publication has 10 references indexed in Scilit:
- Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase.Circulation Research, 1984
- SELECTIVE PF4 RELEASE INVITRO INDUCED BY HEPARIN AND RELATED GLYCOSAMINOGLYCANS (GAGS) - CORRELATION WITH BETA-TG RELEASE AND PLATELET-AGGREGATION1984
- Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosisThrombosis Research, 1983
- THE HUMAN PLASMIN-DERIVED LIGHT (B) CHAIN.STREPTOKINASE COMPLEX - A 2ND-GENERATION THROMBOLYTIC AGENT1983
- POTENTIATION OF THE ANTI-THROMBOTIC EFFECT OF PROSTACYCLIN BY SIMULTANEOUS ADMINISTRATION OF AMINOPHYLLINE IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS1983
- Reperfusion arrhythmia: A marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarctionAmerican Heart Journal, 1983
- Determinants of arrhythmic death due to coronary spasm: effect of preexisting coronary artery stenosis on the incidence of reperfusion arrhythmia.Circulation, 1982
- Prevention of occlusive coronary artery thrombosis by prostacyclin infusion in the dog.Circulation, 1981
- Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregationThrombosis Research, 1981
- Electrical induction of coronary artery thrombosis in the ambulatory canine: A model for evaluation of anti-thrombotic agentsThrombosis Research, 1980